Heparin, Low-Molecular-Weight

"Heparin, Low-Molecular-Weight" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.

Descriptor ID	D006495
MeSH Number(s)	D09.698.373.400.300
Concept/Terms	Heparin, Low-Molecular-Weight Heparin, Low-Molecular-Weight Heparin, Low Molecular Weight LMWH Low Molecular Weight Heparin Low-Molecular-Weight Heparin

Below are MeSH descriptors whose meaning is more general than "Heparin, Low-Molecular-Weight".

Chemicals and Drugs [D]
Carbohydrates [D09]
Polysaccharides [D09.698]
Glycosaminoglycans [D09.698.373]
Heparin [D09.698.373.400]
Heparin, Low-Molecular-Weight [D09.698.373.400.300]

Below are MeSH descriptors whose meaning is related to "Heparin, Low-Molecular-Weight".

Below are MeSH descriptors whose meaning is more specific than "Heparin, Low-Molecular-Weight".

Heparin, Low-Molecular-Weight
Dalteparin
Enoxaparin
Nadroparin

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heparin, Low-Molecular-Weight" by people in this website by year, and whether "Heparin, Low-Molecular-Weight" was a major or minor topic of these publications.

Bar chart showing 19 publications over 14 distinct years, with a maximum of 3 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2001	0	1	1
2002	1	1	2
2003	0	1	1
2005	1	0	1
2006	1	0	1
2007	1	2	3
2009	1	1	2
2010	1	1	2
2012	1	0	1
2013	0	1	1
2014	1	0	1
2015	0	1	1
2020	0	1	1

Below are the most recent publications written about "Heparin, Low-Molecular-Weight" by people in Profiles.

Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke. 2020 09; 51(9):2724-2732.

View in: PubMed
Kapoor A, Ellis A, Shaffer N, Gurwitz J, Chandramohan A, Saulino J, Ishak A, Okubanjo T, Michota F, Hylek E, Trikalinos TA. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost. 2017 02; 15(2):284-294.

View in: PubMed
Huang W, Anderson FA, Rushton-Smith SK, Cohen AT. Impact of thromboprophylaxis across the US acute care setting. PLoS One. 2015; 10(3):e0121429.

View in: PubMed
Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, Yung M, Truemper E, Qin L, Li S, Marohn K, Randolph AG. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med. 2014 May; 42(5):1232-40.

View in: PubMed
Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R, Shermock K, Chelladurai Y, Singh S, Segal JB. Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg. 2013 Jul; 148(7):675-86.

View in: PubMed
Rothberg MB, Pekow PS, Lahti M, Lindenauer PK. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients. J Hosp Med. 2012 Jul-Aug; 7(6):457-63.

View in: PubMed
Kociol RD, Hammill BG, Hernandez AF, Klaskala W, Mills RM, Curtis LH, Fonarow GC. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims. Clin Cardiol. 2011 Nov; 34(11):682-8.

View in: PubMed
Friedman RJ, Gallus A, Gil-Garay E, FitzGerald G, Cushner F. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ). 2010 Sep; 39(9 Suppl):14-21.

View in: PubMed
Grissinger MC, Hicks RW, Keroack MA, Marella WM, Vaida AJ. Harmful medication errors involving unfractionated and low-molecular-weight heparin in three patient safety reporting programs. Jt Comm J Qual Patient Saf. 2010 May; 36(5):195-202.

View in: PubMed
L?pez-Send?n J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J. 2010 Jun; 31(12):1449-56.

View in: PubMed

People

Explore

Similar Concepts

Top Journals